Dr. Reddy’s Laboratories Ltd (REDY)

4,712.70
+41.65(+0.89%)
  • Volume:
    59,196
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    4,679.90 - 4,802.00
  • Type:Equity
  • Market:India
  • ISIN:INE089A01023
  • S/N:DRREDDY

REDY Overview

Prev. Close
4,671.05
Day's Range
4,679.9-4,802
Revenue
195.66B
Open
4,679.9
52 wk Range
4,135.9-5,613.65
EPS
104.47
Volume
59,196
Market Cap
781.5B
Dividend (Yield)
25.00
(0.54%)
Average Vol. (3m)
50,393
P/E Ratio
45.09
Beta
0.18
1-Year Change
4.22%
Shares Outstanding
165,828,913
Next Earnings Date
Nov 04, 2021
What is your sentiment on Dr. Reddy’s Laboratories Ltd?
or
Market is currently closed. Voting is open during market hours.

Dr. Reddy’s Laboratories Ltd News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellStrong SellStrong SellBuy
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Buy
SummaryStrong SellStrong SellStrong SellStrong SellStrong Buy

Dr. Reddy’s Laboratories Ltd Company Profile

Dr. Reddy’s Laboratories Ltd Company Profile

Employees
22739
Market
India

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Proprietary Products segment focuses on the research, development, and commercialization of differentiated formulations for dermatology and neurology therapeutic areas. The Others segment engages in developing therapies in the fields of oncology and inflammation. As of March 31, 2021, it had three late stage projects at various stages of development. Its therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. The company has a collaboration, license, and option agreement with Curis, Inc. to discover, develop, and commercialize small molecule antagonists for immuno-oncology and precision oncology targets. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Read More
  • exit now. buy again at 3600 in Mid October.
    0
    • sell tgt 3800
      1
      • Dr Reddy Target 6000+6200next expires
        2
        • Dr Reddy Target 6000+6200next expires
          0
          • Buy HINDCOPPER at 145-147 Target 170 to 200++
            0
            • today dr reddy high??
              0
              • today dr reddy high??
                0
                • Monday 5 July dr ready tgt 5700 +++
                  1
                  • dr ready tgt Monday
                    1
                    • DR REDDY'S TARGET ACHIVED 5450 PLZ EXIT or put Trending stop lose 5440 and hold for today 3.25pm and close around 5470 or 5480
                      0
                      • will it survives? after reaching its all time high
                        0
                        • Dr Reddy has been consolidating in the 5100 -5300 range. This is the time to accumulate it. Soon Sputnik-V and 2DG will hit the market. By 2nd week of June Dr Reddy will be playing a huge role in the Covid recovery scenario. Expect a sharp move from here. Dont be surprised if it tests 6000 levels in short term.
                          0
                          • dr reddy picking time will be start drd powder corona medicine selling in india in large amount
                            0
                            • It is at its market high and if corona spike doesnt come down , then its going up just like nestle
                              0
                              • DR Reddy Monday Target 5410-5475-5565
                                0
                                • DR REEDY TARGET TODAY 5425
                                  0
                                  • I THINK IT WILL MAITAIN THIS PRICE TILL THE END OF MAY AFTER THAT IT WILL BREAKOUT
                                    0
                                    • is it right time to buy
                                      0
                                      • in today it will 4800
                                        0
                                        • it can be fall byy 200 points
                                          0
                                          • i think its going to be the game changer
                                            0
                                            • target:- 5100-5200 in 2-3 week...............
                                              4
                                              • target:- 5100-5200 in 2-3 week
                                                0
                                                • Hello Sir!
                                                  0
                                                • Hello Sir
                                                  0
                                              • Dr reddy is a mammoth
                                                0
                                                • Dr. Reddy labsCMP 4428, next low between 2680 to 2300, then up side 4100 to 4665, then down side 1535 to 850, then only goes uptrend.
                                                  7
                                                  Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                                  Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.